Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion
2024 · Annals of Allergy Asthma & Immunology · 10 citations
https://doi.org/10.1016/j.anai.2024.04.033
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
144
Citations
8
h-index
8
i10-index
Mike Di Spirito is an academic researcher from Celerion (Canada). The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Lipoproteins and Cardiovascular Health & Food Allergy and Anaphylaxis Research. The author has an h-index of 8, co-authored 9 publications.
Click to start Chat